BMS 186318

BMS 186318 is an HIV protease inhibitor. BMS 186318 exhibits better anti-HIV efficacy when used in combination with reverse transcriptase inhibitors such as Stavudine (HY-B0116) and other protease inhibitors such as Saquinavir (HY-17007) . BMS 186318 can be used in antiviral research[1].

Product Specifications

CAS Number

[161302-40-5]

UNSPSC

12352005

Target

HIV; HIV Protease

Related Pathways

Anti-infection; Metabolic Enzyme/Protease

Applications

COVID-19-anti-virus

Field of Research

Infection

Smiles

CC(C)(C)OC(N[C@@H](CC1=CC=CC=C1)[C@H](O)CNC[C@@H](O)[C@H](CC2=CC=C(OCC(N3CCOCC3)=O)C=C2)NC(OC(C)(C)C)=O)=O

Molecular Formula

C36H54N4O9

Molecular Weight

686.84

References & Citations

[1]Deminie CA, et al. Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication. Antimicrob Agents Chemother. 1996 Jun;40 (6) :1346-51.